Samer Shamout, MD
Surgery · Temple, TXNPI 1750061784
Payments from drug & device makers
Across 111 payments — averaging $87.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$5K
- Medtronic$5K
- Cook Medical LLC$179
- Coloplast$133
- Johnson & Johnson$54
- Ferring Pharmaceuticals Inc.$41
- plus $132 from 6 others
What the payments were for
- Grants$310%
- Travel & lodging$5,61058%
- Food & beverage$4,09342%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 24 | $4,644 |
| Medtronic | 69 | $4,551 |
| Cook Medical LLC | 3 | $179 |
| Coloplast | 5 | $133 |
| Johnson & Johnson(2 entities) | 2 | $54 |
| Ferring Pharmaceuticals Inc. | 2 | $41 |
| Angiodynamics, Inc. | 1 | $33 |
| Dilon Technologies, Inc. | 1 | $25 |
| Axonics, Inc. | 1 | $24 |
| Progenics Pharmaceuticals, Inc. | 1 | $19 |
| Caldera Medical, Inc | 1 | $16 |
| Antares Pharma, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INTERSTIM$1,907
- UPSYLON$871
- Solyx SIS System$797
- Advantage System$760
- AMS 700$595
- GENERAL FEMALE SUI$567
- AMS 700 CXR RTE KIT$513
- ALTAVIVA$441
- LITHO 150$125
How this compares
$9,734 in reported general payments places this provider in the 70th percentile of 1,830 surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 47 | $33,688 |
| Estradiol | 57 | $5,132 |
| Solifenacin Succinate | 121 | $3,771 |
| Fosfomycin Tromethamine | 14 | $2,016 |
| Fesoterodine Fumarate ErFesoterodine Fumarate | 30 | $1,903 |
| Tamsulosin Hcl | 62 | $1,556 |
| Methenamine Hippurate | 14 | $1,258 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 26 | $517 |
| Trospium Chloride | 12 | $359 |
| Oxybutynin Chloride | 14 | $267 |
| Cephalexin | 30 | $244 |
| Ciprofloxacin Hcl | 21 | $62 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 17 | $52 |
| Tramadol Hcl | 12 | $26 |
Paid to pharmacies, not to this prescriber.
Other surgery in Temple
- Monique HassanTemple$192K
- Funda MericHouston$20.6M
- Michael HarkinsTomball$2.7M
- Lloyd StegemannCorpus Christi$1.9M
- Douglas StoddardAustin$1.4M
- Erik WilsonBellaire$1.2M
- Thomas SerenaShenandoah$1.2M
- Steven FassAustin$989K
- Vineet ChoudhryAustin$924K
- Isidoro WienerHouston$850K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.